Advertisement
Please ask to be connected to Q3 2009 Simcere Pharmaceutical GroupEarnings Conference Call and provide the following passcode: 32750293.
Simcere will also broadcast a live audio webcast of the conference call.The broadcast will be available by visiting the "Investor Relations" sectionof the company's web site at http://www.simcere.com .
Advertisement
The passcode for replay participants is: 77133325.The telephone replayalso will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.
About Simcere Pharmaceutical Group
Simcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leadingpharmaceutical company specializing in the development, manufacturing, andmarketing of branded generic and proprietary pharmaceuticals in China. Inrecent years, Simcere has been focusing its strategy on the development ofinnovative pharmaceuticals and first-to-market generics, and has introduced aninnovative anti-cancer medication Endu, a first-to-market medication Sinofuan,and first-to-market generics such as Bicun and Anxin. Simcere manufactures andsells anti-infective medication, anti-cancer medication and stroke managementmedication. Simcere concentrates its research and development efforts on thetreatment of diseases with high incidence and/or mortality rates and for whichthere is a clear demand for more effective pharmacotherapy such as cancer,strokes, orthopaedics and infectious diseases. For more information aboutSimcere Pharmaceutical Group, please visit http://www.simcere.com .To access the conference call, please dial: United States toll-free: +1.800.706.7741 International: +1.617.614.3471 North China toll-free: 10.800.152.1490 South China toll-free: 10.800.130.0399 China toll free / Netcom: 10.800.852.1490 Hong Kong: +852.3002.1672
SOURCE Simcere Pharmaceutical Group
